AAVs in Retinal Gene Therapy
Type
Blog Post
...in the limelight. On December 19, 2017 the FDA approved Luxturna™ the first gene therapy for the treatment...AAV-based gene therapy treatment for a genetic disease approved by the FDA is for a rare eye disease and not another...trial started, and 10 more years to obtain FDA approval and make history in the form of Luxturna™.
A ...medicine.
References and further reading
1. FDA approves gene therapy for blindness
2. Gene Therapy emerges...-1250015778
7. Yu W and Wu Z., 2018. In vivo Applications of CRISPR-Based Genome Editing in the Retina...